We read with great interest the study by Priano titled "Early efficacy of intra-articular HYADD® 4 (Hymovis®) injections for symptomatic knee osteoarthritis."
1 The author would like to explore the efficacy of intra-articular HYADD 4 (Hymovis) injections for symptomatic knee osteoarthritis. tion of a rehabilitation program, giving the clinician data about spatial-temporal parameters, kinematic and kinetic alterations, and about the surface electrical muscle activity using surface electromyography. In conclusion, gait analysis is easily applicable to most of the patients, without side effects. Hence, this instrumentation is suitable for follow-up evaluations and permits to assess any variations of walking biomechanics over time.
As an example, we would like to present a case of a patient (female, 42 years old) affected by knee osteoarthritis (II gradeKellgren and Lawrence classification), treated with two intraarticular injection of mobile reticulum hyaluronic acid, evaluated with gait analysis before treatment and 6 months after the treatment. In our patients is evident the improvement of the flexion-extension kinematic as a consequence of the treatment performed, in particular, we would like to underline the amelioration of the first flexion peak at the loading response phase of the walking cycle (►Fig. 1). Finally, we would like to underline how gait analysis could represent very important outcome measurement to determinate the efficacy of intra-articular injection therapy to treat knee osteoarthritis.
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